查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439202

全球微創脊椎技術市場評估：依技術、依條件、依最終使用者、按地區、機會、預測（2017-2031）

Minimally Invasive Spine Technologies Market Assessment, By Technique, By Condition, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 230 Pages | 商品交期: 3-5個工作天內

價格

全球微創脊椎技術市場規模預計將從2023年的12.1億美元增長到2031年的24.8億美元，預測期內複合年增長率為9.36%。Masu。

預計，在微創手術需求增加、脊椎疾病盛行率上升、患者安全性和依從性提高以及手術工具技術進步等因素的影響下，微創脊椎技術市場將成長。

對微創脊椎手術的需求不斷增加

由於多種因素，包括先進技術、改進的疼痛管理和經濟考慮，對微創脊椎手術的需求正在增加。 微創脊椎手術現已取得重大技術進步，使得這些方法在治療各種脊椎疾病方面更有效率和更有效。 微創脊椎手術可以減少術中失血、減輕術後疼痛、加速功能恢復。 各大公司都在積極推出產品以滿足不斷成長的需求。

脊椎疾病盛行率不斷上升

由於脊椎疾病的盛行率不斷增加，微創脊椎技術的市場預計將擴大。 由於與年齡有關的脊椎磨損，老年人更容易患脊椎疾病。 因此，脊椎疾病的病例預計將顯著增加。 肥胖、長時間坐著工作、營養缺乏、缺乏運動以及導致脊椎損傷的事故發生率高等因素也被認為是脊椎疾病高發生率的原因。

微創脊椎手術的技術進步

近年來，微創脊椎手術取得了重大技術進步。 最重要的技術發展包括脊椎手術中內視鏡的使用、導航引導的脊椎融合以及脊椎手術中的 O 型臂導航。 隨著技術的進步，微創脊椎手術正在擴大其用途，包括簡單的椎管狹窄和複雜的脊椎病理，例如轉移、創傷和成人脊椎畸形。 機器人系統預計將成為脊椎手術的重要組成部分。 由市場主要參與者創建創新解決方案的 R&R 正在推動市場需求。

本報告調查了全球微創脊椎技術市場，提供市場定義和概述、市場規模趨勢和預測、各個細分市場和地區的詳細分析、行業結構以及影響市場成長的因素。分析、案例研究、競爭格局，以及主要公司的簡介。

目錄

第一章研究方法

第 2 章專案範圍與定義

第 3 章執行摘要

第四章全球微創脊椎技術市場展望

  • 市場規模/預測
  • 按技術
    • 內視鏡檢查
    • 導航
    • 機器人
  • 按症狀
    • 椎間盤突出
    • 椎管狹窄
    • 退化性椎間盤疾病
    • 脊椎畸形
    • 椎骨骨折
    • 脊髓感染
    • 脊髓腫瘤
  • 按最終用戶
    • 醫院
    • 門診手術中心
    • 骨科診所
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美洲
    • 中東/非洲
  • 各公司的市佔率

第五章全球微創脊椎技術市場前景（按地區）

  • 北美
  • 歐洲
  • 亞太地區
  • 南美洲
  • 中東/非洲

第 6 章市場映射

  • 按技術
  • 按症狀
  • 按最終用戶
  • 按地區

第七章宏觀環境與產業結構

  • 需求與供給分析
  • 匯入/匯出分析
  • 價值鏈分析
  • PESTEL 分析
  • 波特五力分析

第 8 章市場動態

  • 生長促進因素
  • 抑製成長的因素（問題、限制因素）

第 9 章監理架構與創新

  • 臨床試驗
  • 專利情況
  • 監理機關的核准
  • 創新/最新技術

第十章主要公司狀況

  • 前 5 名市場領導者的競爭矩陣
  • 前 5 位市場領導者的市場收入分析
  • 併購/合資企業（如果適用）
  • SWOT 分析（5 家參與公司）

第11章價格分析

第 12 章案例研究

第十三章主要公司展望

  • B. Braun SE
  • Boston Scientific Corporation
  • Globus Medical, Inc.
  • Medtronic plc
  • Precision Spine, Inc.
  • Richard Wolf GmbH
  • Stryker Corporation
  • Intuitive Surgical, Inc.
  • Zimmer Biomet Holdings, Inc.
  • Johnson & Johnson Services, Inc.

第 13 章策略建議

第14章關於我們公司/免責聲明

Product Code: MX11038

Global minimally invasive spine technologies market is projected to witness a CAGR of 9.36% during the forecast period 2024-2031, growing from USD 1.21 billion in 2023 to USD 2.48 billion in 2031F. The minimally invasive spine technologies market is anticipated to thrive under the influence of factors such as the growing demand for minimally invasive surgeries, the rising prevalence of spine disorders, enhanced patient safety and compliance through such surgeries, and technological advancements in surgical tools.

Minimally invasive spine technologies refer to surgical techniques and technologies that aim to minimize surgical morbidity and achieve surgical outcomes as traditional open surgery while reducing iatrogenic tissue trauma and postoperative pain and disability in spine surgeries. Minimally invasive spine technologies have expanded their utility to simple spinal stenosis and complex spinal pathologies such as metastasis, trauma, or adult spinal deformity. The techniques and technology in minimally invasive spine technologies include spinal endoscopy, intraoperative fluoroscopy/CT, and minimally invasive spinal instrumentation technologies.

In upcoming years, the demand for minimally invasive spine surgeries is expected to grow owing to its multifactorial advantages, such as reduced hospital stay, lesser trauma, and faster recovery, which ultimately expands the growth of the minimally invasive spine technologies market.

However, the major challenge to the market is the high cost of instruments used and the complexities of procedures. Strict regulatory requirements and approval processes for such surgeries are tricky for manufacturers. Challenges associated with adopting robotics and technology in surgery hinder market growth. Lack of technical expertise and training modules associated with minimally invasive surgeries is another major challenge for the market.

In January 2024, Providence Medical Technology announced FDA approval of CAVUX FFS-LX Lumbar Facet Fixation System for 1st and 2nd level lumbar spinal fusion. CAVUX FFS-LX is a bilateral implant system for treating lumbar degenerative disc disease. It is a cage and screw system that provides stabilization for first or second-level lumbar interbody fusion. It can be used with or without pedicle screws and rods and is implanted using the CORUS Spinal System-LX.

Growing Demand for Minimally Invasive Spine Surgeries

The demand for minimally invasive spine surgeries is increasing due to various factors such as advanced techniques, improved pain management, and economic considerations. The current state of minimally invasive spine surgery has witnessed significant technological advancements, making these approaches more efficient and effective for managing different spinal disorders. The emergence of outpatient minimally invasive spine surgery is driven by the need to balance the desire to treat patients with a clear understanding of the economic implications of healthcare. The cost of surgery must be weighed against the societal cost of back pain, which is quite high. Minimally invasive spine surgeries are associated with reduced intraoperative blood loss, postoperative pain, and greater and earlier restoration of function. Key players actively make product launches to cater to the growing demand.

For instance, in December 2023, Ulrich Medica USA announced that it got FDA clearance to expand indications for its Momemtum and Momentum minimally invasive posterior spine systems. The systems can be used with G21 V-STEADY radiopaque bone cement to stabilize, fix, and correct the thoracolumbar and sacroiliac spine.

Growing Prevalence of Spine Disorders

The minimally invasive spine technologies market is expected to expand due to the increasing prevalence of spinal disorders. The elderly population is more susceptible to spinal disorders due to wear and tear of the spine that comes with aging. It is expected to lead to a significant increase in spinal disorder cases. Factors such as obesity, long hours of sitting among working professionals, nutritional deficiencies, lack of physical exercise, and a high number of accidents leading to spinal injuries are expected to contribute to a high prevalence of spinal disorders. Inherited disorders, inflammations, and infections that damage the spine contribute to the growth in the prevalence of spinal disorders.

According to estimates by World Spine Care, around 1 billion people worldwide suffered from spine pain. Each year, approximately 72% of the global population is expected to experience back pain, while around 59% of people are identified with back pain at any given time. Lower back pain is the primary cause of disability, and neck pain is the fourth leading cause of disability, globally, as estimated by World Spine Care.

Technological Advancements in Minimally Invasive Spine Surgery

Minimally invasive spine surgery has seen significant technological advancements in recent years. Some of the most important technological developments include employing an endoscope in spine surgery, navigation-guided spinal fusion, and O-arm navigation in spine surgery. With technical and technological advancements, MISS has expanded its utility to simple spinal stenosis and complex spinal pathologies such as metastasis, trauma, or adult spinal deformity. Robotic systems are expected to become a bigger part of spine surgery. Research and developments by key market players and stakeholders to produce innovative solutions are driving the demand in the market.

In May 2023, Globus Medical, Inc. received approval from the US Food and Drug Administration for its first humanitarian device, the REFLECT Scoliosis Correction System. The system is designed to correct progressive scoliosis in young patients while preserving motion, maintaining stability, and allowing for future modulated growth.

Dominance of Endoscopy Segment

Endoscopy technology used for minimally invasive spine surgeries is anticipated to be the leading segment. Endoscopic spinal surgeries offer advantages such as less soft tissue dissection, reduced blood loss, minimal damage to normal structures, decreased epidural scarring, shorter hospital stay, and earlier functional recovery, thus preferred over other spinal surgeries. Additionally, endoscopic spine surgery can effectively treat conditions such as herniated discs, bulging discs, foraminal stenosis, and degenerative lumbar disease. Several product launches have happened to cater to the endoscopic spinal surgery market.

In October 2023, Joimax launched a new surgical system called the iLESSYS Biportal Interlaminar Endoscopic Surgical System. The system was introduced at two major events, EUROSPINE 2023 Annual Meeting in Frankfurt and SMISS Annual Forum (Society for Minimally Invasive Spine Surgery) in Las Vegas. The iLESSYS Biportal is designed to treat spinal disorders and features a set of instruments tailor-made for biportal spinal endoscopy. One of the system's key features is that it separates the instrument's working port from the endoscope, allowing for greater flexibility and range of motion during surgery.

Ambulatory Surgical Centers to be the Fastest Growing End-user Segment

New techniques, better anesthesia, and improved pain control make same-day back surgeries outstanding growth opportunities for ambulatory settings. Owing to the advantages of ambulatory surgical centers, such as reduced hospital stays, higher success rates, and lower costs, there is an increased number of spinal surgeries being performed at ambulatory surgical centers, showing a drastic shift from preference to hospital settings to ambulatory setups. Additionally, surgeons prefer ambulatory surgical centers to reduce hospital resource utilization. Overall, the clinical advantages of outpatient spine surgery are beneficial, but it has economic advantages that are most convincing in the case of ambulatory surgical centers. For instance, the Ambulatory Surgery Center Association reports an 80% increase in surgeries performed at ASCs.

North America to Dominate the Market

The number of minimally invasive spine surgeries performed in the United States is higher than in other countries due to several factors, including the widespread employment of minimally invasive and endoscopic spinal surgery techniques by spine surgeons in the United States. While Asia is a hotspot for these techniques, the United States is renowned for its excellence in minimally invasive spine surgery, offering patients quicker recovery times, reduced pain, and minimal scarring.

Regional variations in acceptance and utilization of minimally invasive spinal surgery techniques among spine surgeons play a role, with the United States showing a high level of acceptance and utilization of these techniques. The United States being a highly contributing country in North America, helps in establishing dominance of the region in the minimally invasive spine technologies market.

Future Market Scenario (2024 - 2031F)

Accelerated development of innovative robotic-assisted spine surgeries is anticipated to exponentially expand the minimally invasive spine technologies market in the future. Regulatory emphasis on developing and approving such products drives further market expansion. For instance, in August 2023, Wenzel Spine received clearance from the US Food and Drug Administration (FDA) for its primaLOK SP system. According to the company, it marks a significant advancement in spinal fusion technology, providing surgeons and patients with a highly effective and reliable solution for spinal stabilization. The primaLOK SP system incorporates innovative engineering and patient-focused design, offering a comprehensive solution for spinal fusion procedures. The latest FDA clearance allows for the primaLOK SP system to be used at multiple levels, including the treatment of patients with lumbar spinal stenosis.

Key Players Landscape and Outlook

The key players in the minimally invasive spine technologies market are engaged in product development, strategic alliances, and business growth strategies such as partnerships, agreements, and collaborations to drive market value. Regulatory approvals for new products and services and expansion of permitted indications for existing products drive the growth of players and the market.

In May 2023, Novarad's VisAR, a surgical navigation system that employs augmented reality, gained clearance from Indonesia's FDA for intraoperative use in stereotactic spinal surgery. VisAR is effective in both open and minimally invasive surgery (MISS). Advanced technology enables surgeons to convert a patient's imaging data into a 3D hologram that can be precisely projected onto the patient's body. It helps surgeons focus purely on the surgical goal without diverting their attention to a separate monitor, allowing for accurate surgical guidance.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Minimally Invasive Spine Technologies Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Technique
    • 4.2.1. Endoscopy
    • 4.2.2. Navigation
    • 4.2.3. Robotics
  • 4.3. By Condition
    • 4.3.1. Herniated Disc
    • 4.3.2. Spinal Stenosis
    • 4.3.3. Degenerative Disc Disease
    • 4.3.4. Spinal Deformity
    • 4.3.5. Spinal Fracture
    • 4.3.6. Spinal Infection
    • 4.3.7. Spinal Tumor
  • 4.4. By End-user
    • 4.4.1. Hospitals
    • 4.4.2. Ambulatory Surgical Centers
    • 4.4.3. Orthopedics Clinics
  • 4.5. By Region
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia-Pacific
    • 4.5.4. South America
    • 4.5.5. Middle East and Africa
  • 4.6. By Company Market Share (%), 2023

5. Global Minimally Invasive Spine Technologies Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Technique
      • 5.1.2.1. Endoscopy
      • 5.1.2.2. Navigation
      • 5.1.2.3. Robotics
    • 5.1.3. By Condition
      • 5.1.3.1. Herniated Disc
      • 5.1.3.2. Spinal Stenosis
      • 5.1.3.3. Degenerative Disc Disease
      • 5.1.3.4. Spinal Deformity
      • 5.1.3.5. Spinal Fracture
      • 5.1.3.6. Spinal Infection
      • 5.1.3.7. Spinal Tumor
    • 5.1.4. By End-user
      • 5.1.4.1. Hospitals
      • 5.1.4.2. Ambulatory Surgical Centers
      • 5.1.4.3. Orthopedics Clinics
    • 5.1.5. United States*
      • 5.1.5.1. Market Size & Forecast
      • 5.1.5.1.1. By Value
      • 5.1.5.1.2. By Volume
      • 5.1.5.2. By Technique
      • 5.1.5.2.1. Endoscopy
      • 5.1.5.2.2. Navigation
      • 5.1.5.2.3. Robotics
      • 5.1.5.3. By Condition
      • 5.1.5.3.1. Herniated Disc
      • 5.1.5.3.2. Spinal Stenosis
      • 5.1.5.3.3. Degenerative Disc Disease
      • 5.1.5.3.4. Spinal Deformity
      • 5.1.5.3.5. Spinal Fracture
      • 5.1.5.3.6. Spinal Infection
      • 5.1.5.3.7. Spinal Tumor
      • 5.1.5.4. By End-user
      • 5.1.5.4.1. Hospitals
      • 5.1.5.4.2. Ambulatory Surgical Centers
      • 5.1.5.4.3. Orthopedics Clinics
    • 5.1.6. Canada
    • 5.1.7. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.1.6. Germany
    • 5.1.7. France
    • 5.1.8. Italy
    • 5.1.9. United Kingdom
    • 5.1.10. Russia
    • 5.1.11. Netherlands
    • 5.1.12. Spain
    • 5.1.13. Turkey
    • 5.1.14. Poland
  • 5.2. Asia-Pacific
    • 5.2.6. India
    • 5.2.7. China
    • 5.2.8. Japan
    • 5.2.9. Australia
    • 5.2.10. Vietnam
    • 5.2.11. South Korea
    • 5.2.12. Indonesia
    • 5.2.13. Philippines
  • 5.3. South America
    • 5.3.6. Brazil
    • 5.3.7. Argentina
  • 5.4. Middle East & Africa
    • 5.4.6. Saudi Arabia
    • 5.4.7. UAE
    • 5.4.8. South Africa

6. Market Mapping, 2023

  • 6.1. By Technique
  • 6.2. By Condition
  • 6.3. By End-user
  • 6.4. By Region

7. Macro Environment and Industry Structure

  • 7.1. Demand Supply Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.4.7. Supplier Power
    • 7.4.8. Buyer Power
    • 7.4.9. Substitution Threat
    • 7.4.10. Threat from New Entrant
    • 7.4.11. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 12.1. B. Braun SE
    • 12.1.1. Company Details
    • 12.1.2. Key Management Personnel
    • 12.1.3. Products & Services
    • 12.1.4. Financials (As reported)
    • 12.1.5. Key Market Focus & Geographical Presence
    • 12.1.6. Recent Developments
  • 12.2. Boston Scientific Corporation
  • 12.3. Globus Medical, Inc.
  • 12.4. Medtronic plc
  • 12.5. Precision Spine, Inc.
  • 12.6. Richard Wolf GmbH
  • 12.7. Stryker Corporation
  • 12.8. Intuitive Surgical, Inc.
  • 12.9. Zimmer Biomet Holdings, Inc.
  • 12.10. Johnson & Johnson Services, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

13. Strategic Recommendations

14. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 2. Global Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 3. Global Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 4. Global Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 5. Global Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 6. Global Minimally Invasive Spine Technologies Market Share (%), By Region, 2017-2031F
  • Figure 7. North America Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 8. North America Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 9. North America Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 10. North America Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 11. North America Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 12. North America Minimally Invasive Spine Technologies Market Share (%), By Country, 2017-2031F
  • Figure 13. United States Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 14. United States Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 15. United States Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 16. United States Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 17. United States Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 18. Canada Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 19. Canada Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 20. Canada Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 21. Canada Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 22. Canada Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 23. Mexico Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 24. Mexico Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 25. Mexico Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 26. Mexico Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 27. Mexico Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 28. Europe Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 29. Europe Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 30. Europe Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 31. Europe Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 32. Europe Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Minimally Invasive Spine Technologies Market Share (%), By Country, 2017-2031F
  • Figure 34. Germany Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 35. Germany Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 36. Germany Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 37. Germany Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 38. Germany Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 39. France Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 40. France Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 41. France Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 42. France Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 43. France Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 44. Italy Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 45. Italy Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 46. Italy Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 47. Italy Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 48. Italy Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 49. United Kingdom Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 50. United Kingdom Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 51. United Kingdom Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 52. United Kingdom Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 53. United Kingdom Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 54. Russia Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 55. Russia Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 56. Russia Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 57. Russia Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 58. Russia Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 59. Netherlands Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 60. Netherlands Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 61. Netherlands Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 62. Netherlands Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 63. Netherlands Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 64. Spain Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 65. Spain Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 66. Spain Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 67. Spain Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 68. Spain Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 69. Turkey Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 70. Turkey Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 71. Turkey Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 72. Turkey Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 73. Turkey Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 74. Poland Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 75. Poland Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 76. Poland Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 77. Poland Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 78. Poland Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 79. South America Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 80. South America Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 81. South America Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 82. South America Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 83. South America Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 84. South America Minimally Invasive Spine Technologies Market Share (%), By Country, 2017-2031F
  • Figure 85. Brazil Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 86. Brazil Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 87. Brazil Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 88. Brazil Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 89. Brazil Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 90. Argentina Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 91. Argentina Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 92. Argentina Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 93. Argentina Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 94. Argentina Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 95. Asia-Pacific Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 96. Asia-Pacific Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 97. Asia-Pacific Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 98. Asia-Pacific Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 99. Asia-Pacific Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 100. Asia-Pacific Minimally Invasive Spine Technologies Market Share (%), By Country, 2017-2031F
  • Figure 101. India Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 102. India Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 103. India Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 104. India Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 105. India Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 106. China Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 107. China Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 108. China Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 109. China Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 110. China Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 111. Japan Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 112. Japan Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 113. Japan Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 114. Japan Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 115. Japan Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 116. Australia Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 117. Australia Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 118. Australia Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 119. Australia Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 120. Australia Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 121. Vietnam Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 122. Vietnam Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 123. Vietnam Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 124. Vietnam Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 125. Vietnam Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 126. South Korea Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 127. South Korea Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 128. South Korea Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 129. South Korea Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 130. South Korea Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 131. Indonesia Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 132. Indonesia Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 133. Indonesia Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 134. Indonesia Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 135. Indonesia Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 136. Philippines Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 137. Philippines Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 138. Philippines Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 139. Philippines Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 140. Philippines Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 141. Middle East & Africa Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 142. Middle East & Africa Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 143. Middle East & Africa Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 144. Middle East & Africa Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 145. Middle East & Africa Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 146. Middle East & Africa Minimally Invasive Spine Technologies Market Share (%), By Country, 2017-2031F
  • Figure 147. Saudi Arabia Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 148. Saudi Arabia Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 149. Saudi Arabia Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 150. Saudi Arabia Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 151. Saudi Arabia Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 152. UAE Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 153. UAE Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 154. UAE Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 155. UAE Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 156. UAE Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 157. South Africa Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
  • Figure 158. South Africa Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
  • Figure 159. South Africa Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
  • Figure 160. South Africa Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
  • Figure 161. South Africa Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
  • Figure 162. By Technique Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 163. By Condition Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 164. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023